Josiah Lyn Hawks

3PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT).

Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan

|Feb 16, 2023
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE).

Matthew Gumbleton, Stephanie Allan, Hannah Conway

|Jan 16, 2020
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer.

Neeraj Agarwal, Roberto Nussenzveig, Andrew W Hahn

Pageof 1

Frequent Collaborators

2 joint publications

Neeraj Agarwal

2 joint publications

Kenneth Boucher

2 joint publications

Sumati Gupta

1 joint publications

Roberto Nussenzveig